Deborah A. McDowell of OAW explains how patients can prepare for hair loss before chemotherapy starts.
|Articles|September 15, 2015
Jacquelyn Powers on When Individuals Should Consider Genetic Testing
Author(s)Jacquelyn Powers
Jacquelyn Powers, genetic counselor, Abramson Cancer Center, University of Pennsylvania, discusses when individuals should consider genetic testing.
Advertisement
Jacquelyn Powers, genetic counselor, Abramson Cancer Center, University of Pennsylvania, discusses when individuals should consider genetic testing.
Advertisement
Related to this article
Progression-free survival reached 14.3 months with Enhertu versus 8.3 months with chemotherapy plus Keytruda in HER2-mutant lung cancer.
Dr. Dina Khalaf breaks down three clinical trials testing oral and targeted regimens for acute myeloid leukemia and myelodysplastic syndrome.
Dr. Miguel Gonzales-Velez explains how placebos are used in phase 3 cancer trials, and why joining one does not mean giving up standard treatment.
Advertisement
Advertisement
Trending on CURE
1
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
2
3 More Lung Cancer Breakthroughs From WCLC 2026
3
Myeloma Guidelines Call for Yearly Measurable Residual Disease Testing
4
The Service Dog Who Helped Me Keep Fighting
5